Hämostaseologie, Table of Contents Hamostaseologie 2024; 44(S 01): S81DOI: 10.1055/s-0044-1779184 Abstracts Topics T-12. Gene and cell therapy Characterization of Pre-existing Immunity to AAV5 Authors Author Affiliations K. Lau 1 BioMarin Pharmaceutical Inc., Novato, USA C. Vettermann 1 BioMarin Pharmaceutical Inc., Novato, USA G. de Hart 1 BioMarin Pharmaceutical Inc., Novato, USA B. Hock 1 BioMarin Pharmaceutical Inc., Novato, USA A. Frazer-Abel 2 Exsera BioLabs, University of Colorado School of Medicine, Aurora, USA B. Long 1 BioMarin Pharmaceutical Inc., Novato, USA S. Gupta 1 BioMarin Pharmaceutical Inc., Novato, USA Recommend Article Abstract Full Text References References 1 Klamroth R, Hayes G, Andreeva T, Gregg K. et al. Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A. Hum Gene Ther 2022; 33 (7/8) 432-44
